Apr 14, 2025, 19:22

AACR-AstraZeneca Endometrial Cancer Research Fellowship

The AACR-AstraZeneca Endometrial Cancer Research Fellowship is a two-year grant designed to support postdoctoral or clinical research fellows working on innovative projects directly applicable to endometrial cancer. The fellowship encourages basic, translational, clinical, or population sciences research that will contribute to advancing knowledge and treatments in this area and foster the recipient’s long-term career in cancer research.

Eligibility Criteria:

Must hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field.
Must not be currently pursuing another doctoral degree.
By July 1, 2025, applicants must:
- Hold a mentored research position (postdoctoral fellow, clinical research fellow, or equivalent).
- Have completed their most recent doctoral degree or medical training within the past five years (not before July 1, 2020).
- Work under the supervision of a mentor at an academic, medical, or research institution anywhere in the world.
No citizenship or geographic restrictions (visa status must permit completion of the project if based in another country).
Must be an AACR member in good standing (or apply for membership by the application deadline).

Funding Details:

Amount: 130,000 USD
Duration: 2 years
Use of Funds: Salary, benefits, and limited research-related expenses (supplies, equipment, publications, etc.); not for clinical practice compensation or indirect costs

Deadline:

Application Due: April 22, 2025 at 1:00 PM U.S. Eastern Time
Start of Grant Term: July 1, 2025
Decision Date: June 2025

Further Information:

Apply via ProposalCentral
For eligibility or application questions, contact: [email protected]
For membership support: [email protected]

AACR AACR grants AstraZeneca cancer cancer research funding clinical oncology fellowship Early-career researchers Endometrial cancer Gynecologic Oncology OncoDaily Oncology oncology fellowship postdoctoral research translational research uterine cancer women's cancer research

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...